Home » Topics » BioWorld Science

BioWorld Science
RSS

Dosing underway in phase I trial of AR degrader GT-20029 in China

July 28, 2021

First-in-human study investigates HJV inhibitor DISC-0974 for anemia of inflammation

July 28, 2021

JadiCell reduces lung injury in animal model replicating COVID-19 Delta variant inflammation

July 28, 2021

New phase II trial evaluates Orpathsys for advanced or metastatic MET-amplified gastric cancer

July 28, 2021

Infinity reports data on eganelisib in combination therapy for urothelial cancer and TNBC

July 28, 2021

Boehringer Ingelheim advances development of alteplase for COVID-19 ARDS

July 28, 2021

FXa-DOAC reversal with no thrombogenic potential seen with VMX-C001

July 28, 2021

Ghent University Hybrid CAR-T cell platform has dual anti-HIV effects

July 28, 2021

Discovery novel GPR119 agonist with excellent blood glucose-lowering effects

July 28, 2021

FDA clears IND for lanraplenib in patients with AML

July 28, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
K2 nabs two Antengene bispecific TCEs in $2B license, option deal
BioWorld
MPM Bioimpact-spawned K2 Therapeutics Inc. inked a license deal plus option agreement, worth $980.5 million apiece, to gain ex-China rights to two of Antengene...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...